Objective:
The formation of inhibitors to clotting factors is a serious complication in hemophilia A. Immune tolerance induction (ITI) therapy remains the primary method for eradicating inhibitors. This multicenter retrospective…
Tiffany Maness wanted her first marathon to mean something extra. When she saw that the National Hemophilia Foundation had spots for this year’s TCS New York City Marathon, she didn’t hesitate to sign up. Learn why Tiffany is excited to run her…
We invite you to join the quarterly board of directors meeting for the National Hemophilia Foundation on Thursday, August 19th at 7:00 PM EDT. This meeting will discuss NHF business operations and decisions and is…